Portola Pharmaceuticals, Inc.

( )
PTLA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
AMRNAmarin Corp. Plc 15.28%5.811.6%$137.94m
VRXValeant Pharmaceuticals International, Inc. 5.52%15.6714.1%$92.20m
PRGOPerrigo Co. Plc 3.61%48.786.8%$85.90m
JAZZJazz Pharmaceuticals Plc 3.09%108.472.3%$82.69m
CTLTCatalent, Inc. 4.38%55.032.2%$76.29m
ICLRICON plc 5.00%151.204.2%$74.19m
AXSMAxsome Therapeutics, Inc. 16.70%58.201.9%$72.25m
HZNPHorizon Therapeutics Plc 1.50%31.226.5%$72.11m
UTHRUnited Therapeutics Corp. 1.61%96.5914.3%$71.34m
GWPHGW Pharmaceuticals Plc 6.47%97.656.2%$58.65m
ICPTIntercept Pharmaceuticals, Inc. 6.58%67.0516.8%$44.61m
SAGESAGE Therapeutics, Inc. 3.38%30.018.6%$42.98m
PBHPrestige Consumer Healthcare, Inc. 4.87%40.304.0%$35.53m
PCRXPacira Biosciences, Inc. 2.33%33.3910.4%$31.18m
MYOKMyoKardia, Inc. 6.27%50.152.1%$27.93m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.